Ethyl 4-(butylsulfanyl)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate

Catalog No. :
ACHHLP407
CAS No. :
339031-45-7
Molecular Formula :
C17H20N2O3S
Molecular Weight :
332.42

IUPAC Name:ethyl 4-(butylthio)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate

Ethyl 4-(butylsulfanyl)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-(butylsulfanyl)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate
IUPAC Nameethyl 4-(butylthio)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate
MDL No.MFCD00243744
Molecular FormulaC17H20N2O3S
Molecular Weight332.42
SMILESO=C(C(C(SCCCC)=C1)=NN(C2=CC=CC=C2)C1=O)OCC
InChI KeyNGIUJIKVZQRPNH-UHFFFAOYSA-N
SynonymETHYL 4-(BUTYLSULFANYL)-6-OXO-1-PHENYL-1,6-DIHYDRO-3-PYRIDAZINECARBOXYLATE;ethyl 4-(butylsulfanyl)-6-oxo-1-phenyl-1,6-dihydropyridazine-3-carboxylate;3-Pyridazinecarboxylic acid, 4-(butylthio)-1,6-dihydro-6-oxo-1-phenyl-, ethyl ester
CAS No.339031-45-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHHLP407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHLP407 route product structure diagram
    ACHHLP407339031-45-7
Inquiry

2. ACHHLP407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHHLP407 route product structure diagram
    ACHHLP407339031-45-7
Inquiry

Comments (0)